DK264990A - Purinderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse - Google Patents
Purinderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse Download PDFInfo
- Publication number
- DK264990A DK264990A DK264990A DK264990A DK264990A DK 264990 A DK264990 A DK 264990A DK 264990 A DK264990 A DK 264990A DK 264990 A DK264990 A DK 264990A DK 264990 A DK264990 A DK 264990A
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxy
- amino
- hydrogen
- compounds
- procedures
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 229940083251 peripheral vasodilators purine derivative Drugs 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 150000003212 purines Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 239000001257 hydrogen Substances 0.000 abstract 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 4
- 125000004356 hydroxy functional group Chemical group O* 0.000 abstract 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- -1 hydroxy, mercapto Chemical class 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004185 ester group Chemical group 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
- C07F9/6571—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
- C07F9/657163—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom
- C07F9/657181—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms the ring phosphorus atom being bound to at least one carbon atom the ring phosphorus atom and, at least, one ring oxygen atom being part of a (thio)phosphonic acid derivative
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8801729 | 1988-05-06 | ||
| SE8801729A SE8801729D0 (sv) | 1988-05-06 | 1988-05-06 | Purine derivatives for use in therapy |
| SE8900255 | 1989-01-25 | ||
| PCT/SE1989/000255 WO1989010923A1 (en) | 1988-05-06 | 1989-05-05 | Derivatives of purine, process for their preparation and a pharmaceutical preparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK264990D0 DK264990D0 (da) | 1990-11-05 |
| DK264990A true DK264990A (da) | 1990-11-05 |
| DK174986B1 DK174986B1 (da) | 2004-04-13 |
Family
ID=20372263
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK199002649A DK174986B1 (da) | 1988-05-06 | 1990-11-05 | Anvendelse af purinderivater til fremstilling af et lægemiddel |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP0343133B1 (da) |
| JP (1) | JP2866688B2 (da) |
| KR (1) | KR0141913B1 (da) |
| AT (1) | ATE74603T1 (da) |
| CA (1) | CA1340909C (da) |
| DE (1) | DE68901153D1 (da) |
| DK (1) | DK174986B1 (da) |
| ES (1) | ES2033548T3 (da) |
| FI (1) | FI98729C (da) |
| GR (1) | GR3004482T3 (da) |
| HU (1) | HU207082B (da) |
| IE (1) | IE62066B1 (da) |
| IL (1) | IL90166A (da) |
| MY (1) | MY108541A (da) |
| NZ (1) | NZ229002A (da) |
| PT (1) | PT90478B (da) |
| SE (1) | SE8801729D0 (da) |
| WO (1) | WO1989010923A1 (da) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8904855D0 (en) * | 1989-03-03 | 1989-04-12 | Beecham Group Plc | Pharmaceutical treatment |
| US5728575A (en) * | 1990-02-01 | 1998-03-17 | Emory University | Method of resolution of 1,3-oxathiolane nucleoside enantiomers |
| JPH05509307A (ja) * | 1990-07-19 | 1993-12-22 | ビーチャム・グループ・パブリック・リミテッド・カンパニー | プリンの抗ウイルス性ホスホノ―アルケン誘導体 |
| GB9020932D0 (en) * | 1990-09-26 | 1990-11-07 | Wellcome Found | Heterocyclic compounds |
| US5208221A (en) * | 1990-11-29 | 1993-05-04 | Bristol-Myers Squibb Company | Antiviral (phosphonomethoxy) methoxy purine/pyrimidine derivatives |
| US5360714A (en) * | 1992-08-28 | 1994-11-01 | Fox Chase Cancer Center | Hepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereof |
| US5334525A (en) * | 1992-08-28 | 1994-08-02 | Fox Chase Cancer Center | Hepadnavirus polymerase gene product having RNA-dependent DNA priming and reverse transcriptase activities and methods of measuring the activities thereof |
| US5798340A (en) | 1993-09-17 | 1998-08-25 | Gilead Sciences, Inc. | Nucleotide analogs |
| CA2171868A1 (en) * | 1993-09-17 | 1995-03-23 | Petr Alexander | Method for dosing therapeutic compounds |
| US5656745A (en) * | 1993-09-17 | 1997-08-12 | Gilead Sciences, Inc. | Nucleotide analogs |
| DE19540798A1 (de) * | 1995-11-02 | 1997-05-07 | Hoechst Ag | Alkylxanthinphosphonate und Alkylxanthinphosphinoxide und deren Verwendung als Arzneimittel |
| US20030040467A1 (en) | 1998-06-15 | 2003-02-27 | Mary Ann Pelleymounter | Ig/ob fusions and uses thereof. |
| US5717095A (en) * | 1995-12-29 | 1998-02-10 | Gilead Sciences, Inc. | Nucleotide analogs |
| AU1427097A (en) * | 1995-12-29 | 1997-07-28 | Gilead Sciences, Inc. | Nucleotide analogs |
| US6703394B2 (en) | 1996-02-16 | 2004-03-09 | Medivir Ab | Acyclic nucleoside derivatives |
| US5869493A (en) * | 1996-02-16 | 1999-02-09 | Medivir Ab | Acyclic nucleoside derivatives |
| US6184376B1 (en) | 1997-02-10 | 2001-02-06 | Mediver Ab | Synthesis of acyclic nucleoside derivatives |
| JP2009298785A (ja) * | 1997-02-10 | 2009-12-24 | Medivir Ab | 非環状ヌクレオシド誘導体の合成 |
| CA2572577C (en) * | 1997-02-10 | 2011-04-05 | Medivir Ab | Synthesis of acyclic nucleoside derivatives |
| US6753322B2 (en) | 2000-06-06 | 2004-06-22 | Pfizer Inc | 2-aminocarbonyl-9H-purine derivatives |
| WO2003037860A2 (en) | 2001-10-30 | 2003-05-08 | Conforma Therapeutics Corporation | Purine analogs having hsp90-inhibiting activity |
| TWI332507B (en) | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
| MXPA06002997A (es) | 2003-09-18 | 2007-02-08 | Conforma Therapeutics Corp | Novedosos compuestos heterociclicos como inhibidores- hsp90. |
| AU2006230447A1 (en) | 2005-03-30 | 2006-10-05 | Conforma Therapeutics Corporation | Alkynyl pyrrolopyrimidines and related analogs as HSP90-inhibitors |
| EP2326619B1 (en) | 2008-08-01 | 2019-02-27 | Bioxiness Pharmaceuticals, Inc. | Methionine analogs and methods of using same |
| CN102250126A (zh) * | 2010-05-18 | 2011-11-23 | 北京化工大学 | 一种双嘌呤类衍生物及其合成 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0108285B1 (en) * | 1982-10-14 | 1988-04-20 | The Wellcome Foundation Limited | Antiviral purine derivatives |
| CS233665B1 (en) * | 1983-01-06 | 1985-03-14 | Antonin Holy | Processing of isomere o-phosphonylmethylderivative of anantiomere racemic vicinal diene |
| IL73682A (en) * | 1983-12-20 | 1991-08-16 | Medivir Ab | Antiviral pharmaceutical compositions containing 9-hydroxy aliphatic derivatives of guanine,some new such derivatives and process for their preparation |
| SE8406538D0 (sv) * | 1984-12-21 | 1984-12-21 | Astra Laekemedel Ab | Novel derivatives of purine |
| MY101126A (en) * | 1985-12-13 | 1991-07-31 | Beecham Group Plc | Novel compounds |
-
1988
- 1988-05-06 SE SE8801729A patent/SE8801729D0/xx unknown
-
1989
- 1989-05-03 IL IL9016689A patent/IL90166A/en active IP Right Grant
- 1989-05-04 NZ NZ229002A patent/NZ229002A/en unknown
- 1989-05-05 WO PCT/SE1989/000255 patent/WO1989010923A1/en not_active Ceased
- 1989-05-05 JP JP1505738A patent/JP2866688B2/ja not_active Expired - Fee Related
- 1989-05-05 MY MYPI89000618A patent/MY108541A/en unknown
- 1989-05-05 ES ES198989850146T patent/ES2033548T3/es not_active Expired - Lifetime
- 1989-05-05 CA CA000598887A patent/CA1340909C/en not_active Expired - Fee Related
- 1989-05-05 AT AT89850146T patent/ATE74603T1/de not_active IP Right Cessation
- 1989-05-05 EP EP89850146A patent/EP0343133B1/en not_active Expired - Lifetime
- 1989-05-05 HU HU893004A patent/HU207082B/hu not_active IP Right Cessation
- 1989-05-05 DE DE8989850146T patent/DE68901153D1/de not_active Expired - Fee Related
- 1989-05-05 IE IE147289A patent/IE62066B1/en not_active IP Right Cessation
- 1989-05-15 PT PT90478A patent/PT90478B/pt not_active IP Right Cessation
-
1990
- 1990-01-06 KR KR90700035A patent/KR0141913B1/ko not_active Expired - Fee Related
- 1990-11-05 DK DK199002649A patent/DK174986B1/da not_active IP Right Cessation
- 1990-11-05 FI FI905475A patent/FI98729C/fi active IP Right Grant
-
1992
- 1992-05-05 GR GR920400840T patent/GR3004482T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GR3004482T3 (da) | 1993-03-31 |
| IL90166A (en) | 1996-09-12 |
| DK264990D0 (da) | 1990-11-05 |
| PT90478A (pt) | 1989-11-30 |
| JP2866688B2 (ja) | 1999-03-08 |
| HU207082B (en) | 1993-03-01 |
| EP0343133B1 (en) | 1992-04-08 |
| FI98729B (fi) | 1997-04-30 |
| AU626300B2 (en) | 1992-07-30 |
| IE891472L (en) | 1989-11-06 |
| ATE74603T1 (de) | 1992-04-15 |
| FI98729C (fi) | 1997-08-11 |
| DE68901153D1 (de) | 1992-05-14 |
| DK174986B1 (da) | 2004-04-13 |
| IE62066B1 (en) | 1994-12-14 |
| KR0141913B1 (en) | 1998-06-01 |
| CA1340909C (en) | 2000-02-22 |
| IL90166A0 (en) | 1989-12-15 |
| HU893004D0 (en) | 1991-09-30 |
| JPH03504243A (ja) | 1991-09-19 |
| EP0343133A1 (en) | 1989-11-23 |
| AU3572689A (en) | 1989-11-29 |
| NZ229002A (en) | 1997-05-26 |
| HUT57767A (en) | 1991-12-30 |
| ES2033548T3 (es) | 1993-03-16 |
| WO1989010923A1 (en) | 1989-11-16 |
| PT90478B (pt) | 1994-08-31 |
| MY108541A (en) | 1996-10-31 |
| SE8801729D0 (sv) | 1988-05-06 |
| FI905475A0 (fi) | 1990-11-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK264990A (da) | Purinderivater, fremgangsmaade til fremstilling heraf og farmaceutiske praeparater indeholdende disse | |
| NO166448C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tiazolidindioner. | |
| MX23619A (es) | Derivados de aminoacidos y procedimiento para su preparacion y medicamento que lo contiene. | |
| DK0539204T3 (da) | Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre | |
| EP0786458A3 (en) | Derivatives and analogues of 2-deoxy-2,3-didehydro-n-acetyl neuraminic acid and their use as antiviral agents | |
| IT1178154B (it) | Impiego in terapia di composti di trasferimento di metilolo, relative composizioni farmaceutiche e procedimento per preparare queste | |
| MX9203417A (es) | Compuestos de diarilo antiateroescleroticos. | |
| DK324185D0 (da) | 2-substituerede 1,3-propylidendiphosphonatderivater, deres fremstilling og farmaceutiske praeparater med indhold deraf | |
| EP0353821A3 (en) | Antipsychotic 3-piperazinyl-benzazole derivatives | |
| DK72289A (da) | Cephemcarboxylsyreestere, deres fremstilling og anvendelse | |
| DK149383D0 (da) | Salicylsyrederivater, fremgangsmader til fremstilling deraf, farmaceutiske praeparater pa basis af disse forbindelser og deres anvendelse | |
| DK408083A (da) | Isoquinolinderivater, deres fremstilling og anvendelse | |
| DK623888D0 (da) | 9a-allyl- og propargylderivater af 9-deoxo-9a-aza-9a-homoerythromycin a, farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af antibakterielle laegemidler | |
| DK391982A (da) | Sulfonylurinstoffer, deres fremstilling og anvendelse som farmaceutiske praeparater | |
| DK114286A (da) | Pyridylmethylnaphthylderivater eller fysiologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse som laegemidler | |
| DK73289D0 (da) | Basisk substituerede 5-halogen-thienoisothiazol-3(2h)-on-1,1-dioxider, fremgangsmaade til fremstilling af saadanne forbindelser og farmaceutiske praeparater indeholdende disse | |
| GR861646B (en) | 4-amino-2-(imidazolidin-2-on-1-yl)-pyrimidino-5-carbonic acid -(n-triphthoro - methyl-phenyl)-amides for antithrombotic protection and treatment use and preparation of antithrombotically active medicines | |
| HUT51622A (en) | Process for producing 3-piperidinole-indazole derivatives and pharmaceutical preparations having effect against high blood pressure containing these compounds as active substance | |
| ZA828127B (en) | Pyridazinone-imines and their physiologically tolerated acid addition salts, their preparation, and therapeutic agents containing these compounds | |
| HU901631D0 (en) | Process for the preparation of thienyl-piperazine derivatives and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PBP | Patent lapsed |
Country of ref document: DK |